Healthcare Sales & Marketing Network News: MN-166

Searching News Database: MN-166

HSMN NewsFeed - 16 Oct 2013
MediciNova Appoints Geoffrey O'Brien as Vice President
Biopharmaceuticals Personnel

HSMN NewsFeed - 22 Apr 2009
MediciNova Reports Final Data from Phase II MN-221 Emergency Department Clinical Trial (MN-221-CL-006); Hospitalization Rates Decrease 45 Percent With MN-221 Plus Standardized Care in Asthma Patients
Biopharmaceuticals

HSMN NewsFeed - 23 Dec 2008
MediciNova Proposes to Acquire Avigen, Inc.
Biopharmaceuticals Mergers & Acquisitions

HSMN NewsFeed - 8 Sep 2008
MediciNova to Present At Merriman Curhan Ford's 5th Annual Investor Summit 2008
Biopharmaceuticals

HSMN NewsFeed - 1 Feb 2008
MediciNova's MN-166 Reduces Persistent Black Hole Formation in Multiple Sclerosis Patients
Biopharmaceuticals Neurology

HSMN NewsFeed - 26 Jun 2007
MediciNova Announces New Strategic Initiative
Biopharmaceuticals

HSMN NewsFeed - 27 Mar 2007
MediciNova Announces Positive Clinical Results From MN-166 Phase II Multiple Sclerosis Trial
Biopharmaceuticals Neurology

Return to NewsFeed

Additional items found! 3

Members: click here for search results from The HSMN Archive (password required)

Members Archive contains 3 additional stories matching:
MN-166
(Password required)

FindReps - Find Great Medical Independent Sales Reps without recruiter fees.

FindReps - available on the Apple App Store for iPhone and iPad.